Health knowledge made personal
Join this community!
› Share page:
Search posts:

Cambridge Cognition, developer of computerised neuropsychological tests, to go public in the UK

Posted Mar 25 2013 10:40am

cantabmobileCambridge Cognition, one of the 10 Companies to Watch in 2013/ 2014 according to our latest market report , just announced its plans to go public in the UK’s AIM market.

Cambridge Cognition in £15M AIM IPO (Business Weekly): “… the move will value the business at around £15 million. It is hoped the shares will be admitted to AIM on April 8…The group develops and commercialises computerised neuropsychological tests for sale worldwide, principally in the UK – its main country of operation – the US and Europe…CCL has two established product streams, CANTABelect (for clinical research and trials) and CANTABeclipse (for academic and other research)…A third product, CANTABmobile, an approved Class II medical device, was launched in the UK in May 2012.”

To Learn More:

Post a comment
Write a comment:

Related Searches